Gamma-glutamylcysteine clinical trials
How each study uses gamma-glutamylcysteine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the gamma-glutamylcysteine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Pravat Mandal (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test gamma-glutamylcysteine.
- Jan 2027Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI PatientsPhase 1 · Pravat Mandal
- Sep 2027Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.Phase 1 · Pravat Mandal
- Nov 2027Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine SupplementationPhase 1 · Pravat Mandal
Studies
Open first, then newest update. How each study uses gamma-glutamylcysteine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI PatientsRecruitingPhase 1Pravat MandalNCT07583251Written as Gamma- Glutamylcysteine
- Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine SupplementationRecruitingPhase 1Pravat MandalNCT07050173Written as Gamma-glutamylcysteine (GGC)
- Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.RecruitingPhase 1Pravat MandalNCT07064005Written as Gamma- glutamylcysteine
Codes
What other systems call gamma-glutamylcysteine · ClinicalTrials.gg INT002674
- MeSH (NLM) C017341gamma-glutamylcysteineOne source NLM
- UNII (FDA) M984VJS48P.GAMMA.-GLUTAMYLCYSTEINEConfirmed NLM, Wikidata
- Wikidata Q288236gamma-glutamylcysteineConfirmed NLM, Wikidata
- DrugBank DB03408One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C017341 | gamma-glutamylcysteine | One source NLM |
| UNII (FDA) | M984VJS48P | .GAMMA.-GLUTAMYLCYSTEINE | Confirmed NLM, Wikidata |
| Wikidata | Q288236 | gamma-glutamylcysteine | Confirmed NLM, Wikidata |
| DrugBank | DB03408 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.